Methods of treating infection using anitbiotics and glycogen phosphorylase inhibitors
AssigneePfizer Inc.
InventorsJudith L. Treadway, Joyce Anne Sutcliffe
Life of this patent
Estimating the term…
Abstract
The invention provides methods of treating infection, such as Chlamydia pneumoniae infection, in a mammal comprising administering to a mammal effective amounts of azithromycin and a glycogen phosphorylase inhibitor. The invention also provides methods of treating atherosclerosis by administration of effective amounts of azithromycin and a glycogen phosphorylase inhibitor. Pharmaceutical compositions and kits are also provided.
Claims15
A method of treating a bacterial infection in a mammal comprising administering to a mammal in need of such treatment effective amounts of azithromycin and a glycogen phosphorylase inhibitor.
A method of treating a Chlamydia pneumoniae infection comprising administering to a mammal comprising administering to a mammal in need of such treatment effective amounts of azithromycin and a glycogen phosphorylase inhibitor.
A method of treating atherosclerosis comprising administering to a mammal in need of such treatment effective amounts of azithromycin and a glycogen phosphorylase inhibitor or a pharmaceutically acceptable salt thereof or prodrug thereof.
A pharmaceutical composition comprising, in effective amounts, azithromycin and a glycogen phosphorylase inhibitor or a pharmaceutically acceptable salt thereof and further comprising a pharmaceutical carrier or diluent.
A kit comprising:
- a) azithromycin or a pharmaceutically acceptable salt thereof and a pharmaceutically acceptable carrier or diluent in a first unit dosage form;
- b) a glycogen phosphorylase inhibitor or a pharmaceutically acceptable salt thereof and a pharmaceutically acceptable carrier or diluent in a second unit dosage form;
- and
- c) a container.
A kit comprising:
- a) azithromycin or a pharmaceutically acceptable salt thereof and a pharmaceutically acceptable carrier or diluent in a unit dosage form;
- and
- b) instructions for administering a glycogen phosphorylase to a mammal.
A kit comprising:
- a) a glycogen phosphorylase inhibitor or a pharmaceutically acceptable salt thereof and a pharmaceutically acceptable carrier or diluent in a unit dosage form;
- and
- b) instructions for administering azithromycin to a mammal.
Dependencies are inferred from the claim text.